Team:HKU HongKong/Project/Background.html

From 2012.igem.org

(Difference between revisions)
Line 486: Line 486:
</ul>
</ul>
<p>&nbsp;</p>
<p>&nbsp;</p>
-
<p>&nbsp;</p>
+
<h2 style="font-variant: normal; vertical-align: baseline; clear: left; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin: 0.7em 0px; padding: 0px">
-
<p>&nbsp;</p>
+
-
<p>&nbsp;</p>
+
-
<p>&nbsp;</p>
+
-
<p>&nbsp;</p>
+
-
<div style="clear: both"></div>
+
-
 
+
-
</div>
+
-
<div style="clear: both"></div>
+
-
<!-- header ends -->
+
-
    <!-- table begins -->
+
-
  <div id="tb">
+
-
    <div id="right" style="width: 861px; height: 388px">
+
-
      <h2 style="font-variant: normal; vertical-align: baseline; clear: left; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin: 0.7em 0px; padding: 0px">
+
-
&nbsp;</h2>
+
-
<h2 style="font-variant: normal; vertical-align: baseline; clear: left; color: #232323; font-family: Gentium Basic; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin: 0.7em 0px; padding: 0px">
+
<span style="font-weight: 400; text-decoration:underline">
<span style="font-weight: 400; text-decoration:underline">
<font face="Trebuchet MS" size="6">Abstract</font></span></h2>
<font face="Trebuchet MS" size="6">Abstract</font></span></h2>
 +
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
 +
&nbsp;</p>
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
HKU’s iGEM team aims to introduce  
HKU’s iGEM team aims to introduce  
Line 545: Line 532:
regarded as a potential implication of HKU’s iGEM project.
regarded as a potential implication of HKU’s iGEM project.
-
<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph">
+
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; vertical-align: baseline; color: rgb(85, 85, 85); font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
 +
&nbsp;<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph">
<u><font face="Trebuchet MS">
<u><font face="Trebuchet MS">
<b><font size="6" color="#232323">M</font></b><font size="6" color="#232323">aterials  
<b><font size="6" color="#232323">M</font></b><font size="6" color="#232323">aterials  
Line 553: Line 541:
<i>
<i>
<font color="#232323">Cloning and expressing pvdQ in E. coli</font></i></p>
<font color="#232323">Cloning and expressing pvdQ in E. coli</font></i></p>
-
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
+
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">pvdQ was amplified from genomic DNA of Pseudomonas  
-
<br>
+
-
pvdQ was amplified from genomic DNA of Pseudomonas  
+
Aeruginosa. A functional biobrick is constructed by combining pvdQ and  
Aeruginosa. A functional biobrick is constructed by combining pvdQ and  
some regulatory elements (such as promoter and terminator). The  
some regulatory elements (such as promoter and terminator). The  
Line 569: Line 555:
<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph">
<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph">
<font color="#232323"><i>Testing the inhibitory effect</i></font></p>
<font color="#232323"><i>Testing the inhibitory effect</i></font></p>
-
<p style="text-align: left; font-style: normal; font-variant: normal; font-weight: normal; font-size: 13px; vertical-align: baseline; color: #232323; font-family: Lato, Tahoma, Arial, sans-serif; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; border: 0px none; margin-left: 0px; margin-right: 0px; margin-top: 0px; margin-bottom: 20px; padding: 0px">
+
<p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph">
-
<br>
+
<font color="#232323" face="Tahoma" size="2">The growth rate of monospecies biofilm of <i>
-
The growth rate of monospecies biofilm of
+
Pseudomonas putida</i> is used to reflect the inhibitory effect of  
-
Pseudomonas putida is used to reflect the inhibitory effect of  
+
engineered <i>Escherichia coli</i>. This is because the major AHLs  
-
engineered Escherichia coli. This is because the major AHLs  
+
secreted by it involve 3-oxo-C12, which is a AHL that can be degraded by  
secreted by it involve 3-oxo-C12, which is a AHL that can be degraded by  
PvdQ and is also the major AHL produced in Pseudomonas areuginosa, the  
PvdQ and is also the major AHL produced in Pseudomonas areuginosa, the  
-
pathogenic microorganism. pvdQ expressing E. coli will be mixed  
+
pathogenic microorganism. <i>pvdQ</i> expressing E. coli will be mixed  
with Pseudomonas putida and grown on agar plate. The reduction in  
with Pseudomonas putida and grown on agar plate. The reduction in  
biofilm formation will be assayed by crystal violet assay. The next part  
biofilm formation will be assayed by crystal violet assay. The next part  
of the experiment is to add engineered E. coli to different  
of the experiment is to add engineered E. coli to different  
phases of biofilm to validate the role of AHLs in biofilm formation.</font></p>
phases of biofilm to validate the role of AHLs in biofilm formation.</font></p>
-
  </div> 
 
-
     
 
-
    <!-- table ends -->
 
-
</div>
 
</body>
</body>
 +
</html>
</html>

Revision as of 05:19, 23 September 2012

Team:HKU Hong Kong - 2012

Team:HKU HK

From 2011.igem.org